Guidance executive

Our guidance executive meets weekly to consider and sign off guidance and other products for publication.

It's made up of executive directors, guidance centre directors and senior team members.

The current membership is:

Dr Sam Roberts, chief executive

Dr Sam Roberts

Dr Sam Roberts is the chief executive of NICE.

Before joining us in February 2022, Sam was the managing director of health and care at Legal and General, a financial services firm. In this role, she had responsibility for identifying promising areas for investment across health and care.

Prior to that, Sam was the first chief executive of the Accelerated Access Collaborative. This is a national umbrella organisation for health innovation, hosted by NHS England and NHS Improvement (NHSEI).

She originally trained as a doctor and practiced medicine in South Africa, the UK, and Australia before undertaking an MBA. She then joined McKinsey and Company, where she worked in a wide range of industries before specialising in healthcare.

After McKinsey, Sam moved into the NHS as a senior manager at University College London Hospitals NHS Foundation Trust. She was also a director in UCLPartners, an Academic Health Sciences Centre and Network. Last year, she took on the role of director of innovation, research and life sciences at NHSEI.

Over the last 5 years Sam has become involved in research, working with health economic models to inform evidence-based policy at the London School of Economics. She then moved to the University of Oxford where she undertook a DPhil (Doctor of Philosophy).

Professor Jonathan Benger, CBE MD FRCS FRCEM, chief medical officer and interim director of the centre for guidelines

Jonathan Benger

Jonathan joined us in January 2023 as chief medical officer and from March 2023 will act as interim director of the centre for guidelines.

Prior to this he was the interim chief clinical information officer (CCIO) at NHS England (2022), the chief medical officer (CMO) of NHS Digital (2019 to 2022), and the national clinical director for urgent and emergency care at NHS England (2013 to 2019).

In his clinical work, Jonathan is a consultant in emergency medicine at the Bristol Royal Infirmary and also does regular shifts with the Great Western Air Ambulance, which he established as its first medical advisor between 2007 and 2011.

Jonathan is professor of emergency care in the school of health and social wellbeing at the University of the West of England, and a National Institute for Health Research (NIHR) senior investigator. His main research interests relate to cardiac arrest, emergency and pre-hospital care, service organization and delivery, and design research.

Elaine Cartwright, associate director, resource impact assessment

Elaine Cartwright

Elaine joined us in September 2019 as the associate director for the resource impact assessment team. She was previously a chief finance officer within Betsi Cadwaladr Health Board, where she oversaw the finances for one of the acute hospitals in North Wales and also for managed clinical services across North Wales.

Elaine has extensive experience in finance within the NHS, having also worked for a large acute trust in England. Before working in the NHS, she worked for major international chemical companies and was heavily involved in the flotation of one of these companies on the US stock market.

    Mark Chapman, interim director of medical technology and digital evaluation

    Mark Chapman

    Mark joined us in 2022 as interim director for medical technology and digital evaluation. This includes diagnostics, digital and medtech that can be implantable or assistive. Mark has 30 years of experience in the medtech arena. He initially trained as a Clinical Physiologist, and worked for 10 years within the UK NHS, Tertiary Cardiac Care, with a specialist interest in complex cardiac devices.

    Moving into Industry in 2001, holding various clinical and commercial roles. In parallel, he has held roles, including committee member on our technology appraisal programme. Is a past member of the External Advisory Board, University of Leeds EPSRC Centre for innovative Manufacturing of Medical Devices. Mark has also undertaken secondment within the UK Government, Office for Life science, Department of Business, as MedTech Policy Advisor. Since 2014 Mark was the Director of Health Economics and Commissioning for UK & Ireland at Medtronic.

    Dr Paul Chrisp, head of publishing and products

    Dr Paul Chrisp

    Paul has been with us since March 2009, where he was responsible for setting up our accreditation programme for guideline developers. More recently, he was programme director of the Medicines and Technologies Programme.

    Before joining us, Paul spent over 20 years in international medical publishing and communications, focusing on evidence to aid healthcare decision making and the adoption of new medicines.

    Paul trained as a pharmacist and is a member of the Royal Pharmaceutical Society.

    Dr Felix Greaves, director of science, evidence and analytics

    Dr Felix Greaves

    Felix joined us in 2020 in the new role of director of science, evidence and analytics. He was previously the deputy director of science and strategic information and head of science and engineering profession at Public Health England. He has been closely involved in the development of our public health guidelines.

    With 16 years’ experience in the health service, Felix has worked as a clinical advisor to the chief medical officer for England, a medical officer at the World Health Organization, and governor of an NHS foundation trust. Felix is a consultant in public health medicine and continues to work part time as a public health academic at Imperial College London.

    Helen Knight, director of medicines evaluation

    Helen Knight

    Helen is the director of medicines evaluation at NICE.

    Helen is responsible for designing and operating methods and systems to produce national guidance and other advice on medicines and other relevant therapies for the NHS in England. With an academic background in biochemistry and health economics, and over 20 years of experience in health technology assessment, she has extensive knowledge of the principles of evidence-based healthcare, methods and processes of health technology assessment and experience over a wide range of technologies and disease areas.

    Dr Clare Morgan, director of implementation and partnerships

    Placeholder image

    Clare joined us in December 2022 as director of implementation and partnerships, leading on collaboration with key stakeholders to enable effective implementation of NICE products across health and social care. Her portfolio also includes patient involvement & participation.

    Clare was previously the director of strategy at Liverpool University Hospitals NHS Foundation Trust; leading on organisation and system wide strategy, transformation and partnerships in an integrated care system responsible for tackling some of the worst health inequalities in the UK and Europe. Prior to this Clare was the national life sciences industry and research director for the NIHR Clinical Research Network for thirteen years, during which she spent a year in the South Yorkshire & Bassetlaw Integrated Care System leading on research and innovation. She also brings significant experience of the clinical research ecosystem, gained through roles in contract research organisations, the pharmaceutical industry and within academia.

    Clare has a Doctorate of Philosophy (PhD) in Immunology and an academic background in biomedical sciences.

    Rebecca Smith, associate director, media relations – Communications

    Rebecca Smith

    Rebecca joined NICE in 2016 having spent 15 years working as a journalist, including as medical editor of the Evening Standard and Daily Telegraph.

    Having written about NICE’s work for ten years Rebecca understands the impact our guidance has on patients, the health and care sectors and industry.

    Rebecca joined NICE as head of media and now associate director for the external communications team.